About
ProSomnus is the leading non-CPAP OSA therapy® for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, covered by commercial medical insurance, and sponsored healthcare plans around the world.
Keywords
Company Information
-
Employees 140
-
Founded 2016
-
Annual Revenue $27652000
-
Total Funding $43550000
Location
5675 Gibraltar Dr, Pleasanton, California, United States, 94588-8547
